Skip Navigation
National Cancer Institute Progress Review Groups
OSPA Home PRGs Home Contact Us

About PRGs
Schedule
Snapshots

Brain Tumor
Breast Cancer
Colorectal Cancer
Gynecologic Cancers
Kidney & Bladder Cancers
Leukemia, Lymphoma, &. Myeloma
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Stomach & Esophageal Cancers
  

About the National Cancer Institute's Progress Review Groups

Background: The National Cancer Institute

The National Cancer Institute (NCI) supports basic, clinical, and population-based research to identify and study the causes, biology, prevention, early detection, and treatment of cancer. Through years of dedicated research, we have amassed an enormous knowledge base about cancer, and this knowledge, coupled with new technologies, is providing a wealth of new scientific opportunities. At the same time, our increasing research needs and scientific opportunities require that we determine the best uses for our resources. We need to identify clear scientific priorities, both to provide guidance for the scientific community and to create a benchmark against which we can measure our own progress.

Progress Review Groups

The NCI convenes Progress Review Groups (PRGs) to assist in setting priorities for organ site-specific research. Each PRG is composed of between 21 and 30 prominent members of the scientific, medical and advocacy communities and is charged with outlining and prioritizing a national research agenda for a particular cancer site. Using the NCI's current research program as a baseline, the PRG identifies priority areas for research. The final product of a PRG is a report listing research priorities and the resources that we need if we are to achieve them.

Top of Page

The PRG Report: A National Research Agenda

The priorities identified by each PRG in its Report have a real and proven impact on the NCI's scientific plans and priorities, both within the Institute and throughout our Extramural Program. PRGs provide a framework within which we can determine whether our existing initiatives and programs are sufficient to aid the research community in addressing priority areas, and help us identify areas in which new or additional support is required. PRG reports, by highlighting key research priorities, galvanize the research community to undertake projects in specific areas of scientific need. Because of this influence on researchers and research programs at the NCI and across the Nation, each PRG report can be considered a truly "national" plan.

Top of Page

PRGs: Past, Present and Future

Report Release

Breast Cancer PRG August 1998
Prostate Cancer PRG August 1998
Colorectal Cancer PRG April 2000
Brain Tumor PRG (With the National Institute of Neurological Disorders and Stroke) November 2000
Pancreatic Cancer PRG February 2001
Leukemia, Lymphoma, & Myeloma PRG May 2001
Lung Cancer PRG August 2001
Gynecologic Cancers PRG November 2001
Kidney & Bladder Cancers PRG August 2002
Stomach & Esophageal Cancers PRG December 2002
Sarcoma PRG January 2004

Top of Page

Other U.S. Government Resources

National Institutes of Health (NIH)


Department of Health and Human Services


FirstGov

Last updated 07.10.03 (fsc)